You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cobicistat

Showing 1 - 25 of 155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial (Cobicistat)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Cobicistat
  • (no location specified)
Feb 17, 2023

Drug-drug Interaction Trial in Tempe (PBI-200 Tablet, Ritonavir Oral Tablet, Cobicistat Oral Tablet)

Completed
  • Drug-drug Interaction
  • PBI-200 Tablet
  • +2 more
  • Tempe, Arizona
    Celerion, Inc.
Jan 11, 2023

Healthy Participants Trial in Miami (Atazanavir, Cobicistat, Atazanavir/Cobicistat Mini-tablet)

Completed
  • Healthy Participants
  • Miami, Florida
    Local Institution - 0001
Oct 27, 2022

Healthy Trial in Edegem (DRV/COBI FDC, COBI, DRV)

Completed
  • Healthy
  • DRV/COBI FDC
  • +2 more
  • Edegem, Belgium
    SGS Belgium NV
Oct 25, 2022

Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19

Completed
  • Coronavirus
  • +2 more
  • Doha, Qatar
    Hamad Medical Corporation
Aug 15, 2022

AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

Not yet recruiting
  • AML, Adult
  • Amersfoort, Netherlands
  • +17 more
Aug 23, 2023

CYP3A Inhibitor, Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma Trial in Heidelberg (Cobicistat Oral Tablet)

Not yet recruiting
  • CYP3A Inhibitor
  • Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
  • Cobicistat Oral Tablet
  • Heidelberg, BW, Germany
    University Hospital Heidelberg
Aug 10, 2022

HIV in Adults Trial in Woburn (Atazanavir, Cobicistat, Active Pharmaceutical Ingredient)

Completed
  • HIV in Adults
  • Woburn, Massachusetts
    Senopsys Llc
Dec 15, 2021

HIV Infected Population With Latent Tuberculosis Trial run by the CC (rifapentene (RPT), darunavir/cobicistat (DRV/c), Isoniazid

Completed
  • HIV Infected Population With Latent Tuberculosis
  • rifapentene (RPT)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 15, 2022

Drug-induced QT Prolongation, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Clarithromycin, Pimozide, Placebo (Part 1))

Not yet recruiting
  • Drug-induced QT Prolongation
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Feb 7, 2023

Healthy Participants Trial in Austin (Atazanavir/Cobicistat, Reyataz Atazanavir, Cobicistat)

Completed
  • Healthy Participants
  • Austin, Texas
    PPD Development, LP
Nov 18, 2021

Cancer Trial in Amsterdam, Nijmegen, Rotterdam (Olaparib, Cobicistat)

Recruiting
  • Cancer
  • Amsterdam, Netherlands
  • +2 more
Oct 21, 2022

Human Immunodeficiency Virus (HIV) Trial in South Africa, Spain, United States (DRV/COBI FDC)

Recruiting
  • Human Immunodeficiency Virus (HIV)
  • DRV/COBI FDC
  • Atlanta, Georgia
  • +5 more
Aug 2, 2022

Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir

Completed
  • Healthy
  • Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
  • +3 more
  • Groningen, Netherlands
    PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Aug 3, 2021

Acquired Immune Deficiency Syndrome (AIDS), HIV Trial in Worldwide (ATV, DRV, Cobicistat)

Recruiting
  • Acquired Immune Deficiency Syndrome (AIDS)
  • HIV Infections
  • Long Beach, California
  • +29 more
Aug 18, 2022

HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

Terminated
  • HIV-1-infection
  • Biktarvy Tab
  • Saint Louis, Missouri
    Southampton Healthcare, Inc.
Jan 3, 2023

Non Small Cell Lung Cancer Trial in Maastricht, Amsterdam (Cobicistat)

Completed
  • Non Small Cell Lung Cancer
  • Cobicistat
  • Maastricht, Limburg, Netherlands
  • +1 more
Sep 23, 2022

HIV-1 Infection Trial in All The Regions Of The Country (40 Centers) (Dolutegravir, Darunavir-cobicistat,

Completed
  • HIV-1 Infection
  • All The Regions Of The Country (40 Centers), France
    (unnamed)
Jan 3, 2022

HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

Active, not recruiting
Has Results
  • HIV-1 Infection
  • Doravirine, Tenofovir, Lamivudine
  • +4 more
  • (no location specified)
Sep 2, 2022

Healthy Volunteers Trial in Baltimore (Genvoya Oral dose, Genvoya Crushed Dose)

Completed
  • Healthy Volunteers
  • Genvoya Oral dose
  • Genvoya Crushed Dose
  • Baltimore, Maryland
    Johns Hopkins University
Nov 9, 2021

HIV, Obesity Trial in Greenville (Biktarvy, Symtuza)

Not yet recruiting
  • HIV Infections
  • Obesity
  • Greenville, North Carolina
    Adult Specialty Care Clinic-East Carolina University
Jul 14, 2022

HIV/AIDS Trial in Stanford, Aurora (Darunavir/Cobicistat, Dolutegravir)

Withdrawn
  • HIV/AIDS
  • Stanford, California
  • +1 more
Jul 7, 2021

Cancer Harboring BRAF Alterations Trial (FORE8394, Cobicistat)

Not yet recruiting
  • Cancer Harboring BRAF Alterations
  • (no location specified)
Aug 15, 2022

Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)

Not yet recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1) Infection
  • (no location specified)
Jul 11, 2022

Healthy Trial in Merksem (Dabigatran Etexilate, DRV/COBI, Ritonavir)

Completed
  • Healthy
  • Dabigatran Etexilate
  • +3 more
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jun 8, 2021